Understanding how patients with heart failure with preserved ejection fraction (HFPEF) die provides insight ... better prediction of response to therapy in designing clinical trials.

Global Commercial Launch Preparations Underway for First Potential Approval Towards Building Specialty Cardiovascular Franchise Company Recently Launched Unbranded Disease Awareness Campaign “HCM ...

The novel GLP-1 receptor agonists will likely reduce the need for CABG and improve surgical outcomes, several argue.

For patients with HFPEF and other underlying comorbidities ... taking open-label ACE inhibitors after cessation of blinded therapy—40% of patients taking perindopril and 36% of placebo subjects ...

Retail therapy benefits include improved mood, enhanced imagination, and gaining a sense of control during times of sadness. Retail therapy is motivated by a desire to feel better rather than to meet ...

Among the benefits of semaglutide, the GLP-1 receptor agonist may protect against heart failure events in patients with type 2 diabetes and CKD.

Everyone snores occasionally, but for some, snoring can indicate a more serious issue: sleep disordered breathing. This refers to a range of sleep-related respiratory conditions that include ...

A new scientific statement issued today by the Heart Failure Society of America highlights a critical connection between heart failure (HF) and cancer, with shared mechanisms contributing to the ...

Daily science news on research developments and the latest scientific innovations Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech ...